Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis
- PMID: 29026006
- PMCID: PMC5696455
- DOI: 10.1042/BSR20171301
Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis
Abstract
Pulmonary fibrosis (PF) is characterized by inflammation and fibrosis of the interstitium and destruction of alveolar histoarchitecture ultimately leading to a fatal impairment of lung function. Different concepts describe either a dominant role of inflammatory pathways or a disturbed remodeling of resident cells of the lung parenchyma during fibrogenesis. Further, a combination of both the mechanisms has been postulated. The present review emphasizes the particular involvement of alveolar epithelial type I cells in all these processes, their contribution to innate immune/inflammatory functions and maintenance of proper alveolar barrier functions. Amongst the different inflammatory and repair events the purinergic receptor P2X7, an ATP-gated cationic channel that regulates not only apoptosis, necrosis, autophagy, and NLPR3 inflammosome activation, but also the turnover of diverse tight junction (TJ) and water channel proteins, seems to be essential for the stability of alveolar barrier integrity and for the interaction with protective factors during lung injury.
Keywords: P2X7R; alveolar epithelial type I cell; pulmonary fibrosis.
© 2017 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures




Similar articles
-
P2X7R-dependent regulation of glycogen synthase kinase 3β and claudin-18 in alveolar epithelial type I cells of mice lung.Histochem Cell Biol. 2016 Dec;146(6):757-768. doi: 10.1007/s00418-016-1499-3. Epub 2016 Sep 23. Histochem Cell Biol. 2016. PMID: 27663455
-
P2X7R: independent modulation of aquaporin 5 expression in CdCl2-injured alveolar epithelial cells.Histochem Cell Biol. 2018 Mar;149(3):197-208. doi: 10.1007/s00418-018-1637-1. Epub 2018 Feb 3. Histochem Cell Biol. 2018. PMID: 29397411
-
Susceptibility of microtubule-associated protein 1 light chain 3β (MAP1LC3B/LC3B) knockout mice to lung injury and fibrosis.FASEB J. 2019 Nov;33(11):12392-12408. doi: 10.1096/fj.201900854R. Epub 2019 Aug 20. FASEB J. 2019. PMID: 31431059 Free PMC article.
-
Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis.Am J Respir Cell Mol Biol. 2024 Jul;71(1):30-42. doi: 10.1165/rcmb.2023-0426TR. Am J Respir Cell Mol Biol. 2024. PMID: 38579159 Free PMC article. Review.
-
New insights of P2X7 receptor signaling pathway in alveolar functions.J Biomed Sci. 2013 May 1;20(1):26. doi: 10.1186/1423-0127-20-26. J Biomed Sci. 2013. PMID: 23634990 Free PMC article. Review.
Cited by
-
Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis.Heliyon. 2022 Jun 30;8(8):e09773. doi: 10.1016/j.heliyon.2022.e09773. eCollection 2022 Aug. Heliyon. 2022. PMID: 36061031 Free PMC article. Review.
-
The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin.Front Pharmacol. 2022 Sep 30;13:985223. doi: 10.3389/fphar.2022.985223. eCollection 2022. Front Pharmacol. 2022. PMID: 36249808 Free PMC article.
-
Transitional human alveolar type II epithelial cells suppress extracellular matrix and growth factor gene expression in lung fibroblasts.Am J Physiol Lung Cell Mol Physiol. 2019 Aug 1;317(2):L283-L294. doi: 10.1152/ajplung.00337.2018. Epub 2019 Jun 5. Am J Physiol Lung Cell Mol Physiol. 2019. PMID: 31166130 Free PMC article.
-
Alveolar lipids in pulmonary disease. A review.Lipids Health Dis. 2020 Jun 3;19(1):122. doi: 10.1186/s12944-020-01278-8. Lipids Health Dis. 2020. PMID: 32493486 Free PMC article. Review.
-
Dysregulation of club cell biology in idiopathic pulmonary fibrosis.PLoS One. 2020 Sep 17;15(9):e0237529. doi: 10.1371/journal.pone.0237529. eCollection 2020. PLoS One. 2020. PMID: 32941426 Free PMC article.
References
-
- American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 161, 646–664 - PubMed
-
- Coultas D.B., Zumwalt R.E., Black W.C. and Sobonya R.E. (1994) The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150, 967–972 - PubMed
-
- Byrne A.J., Maher T.M. and Lloyd C.M. (2016) Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease? Trends Mol. Med. 22, 303–316 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous